Lysophosphatidylcholine Promotes P-Selectin Expression in Platelets and Endothelial Cells Possible Involvement of Protein Kinase C Activation and Its Inhibition by Nitric Oxide Donors

Circulation Research

Volumn 78, Issue 5, 1996, Pages 780-789

  Murohara, Toyoaki ^a   Scalia, Rosario ^a   Lefer, Allan M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Cell adhesion molecules; Endothelium; Flow cytometry; Leukocyte adherence; Platelets

Indexed keywords

LYSOPHOSPHATIDYLCHOLINE; PADGEM PROTEIN; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CAT; CELL ADHESION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; FLOW CYTOMETRY; LEUKOCYTE ADHERENCE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; THROMBOCYTE FUNCTION; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD PLATELETS; CATS; CELL ADHESION; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LYSOPHOSPHATIDYLCHOLINES; MALE; NEUTROPHILS; NITRIC OXIDE; NITROPRUSSIDE; OXADIAZOLES; P-SELECTIN; PROTEIN KINASE C; TETRADECANOYLPHORBOL ACETATE; THROMBIN; VASODILATOR AGENTS;

EID: 0029874399     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.78.5.780     Document Type: Article

References (54)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoproteins that increase its atherogenicity. N Engl S Med. 1989;320:915-924.
2. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
3. Munro JM, Cotran RS. Biology of disease: the pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest. 1988; 58:249-261.
4. Chisolm GM. Oxidized lipoproteins and leukocyte-endothelial interactions: growing evidence for multiple mechanisms. Lab Invest. 1993;68:369-371.
5. Lehr H-A, Olofsson AM, Carew TE, Vajkoczy P, von Andrian UH, Hubner C, Berndt MC, Steinberg D, Messmer K, Arfors KE. P-Selectin mediates the interaction of circulating leukocytes with platelets and microvascular endothelium in response to oxidized lipoprotein in vivo. Lab Invest. 1994;71:380-386.
6. 2 activity of apoprotein B100. Proc Natl Acad Sci U S A. 1990;87:9741-9745.
7. Portman OW, Alexander M. Lysophosphatidylcholine concentrations and metabolism in aortic intima plus inner media: effect of nutritionally induced atherosclerosis. J Lipid Res. 1969;10:158-165.
8. Ylä-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest. 1989;84:1086-1095.
9. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature. 1990;344: 160-162.
10. Yokoyama M, Hirata K, Miyake R, Akita H, Ishikawa Y, Fukuzaki H. Lysophosphatidylcholine: essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein. Biochem Biophys Res Commun. 1990;168:301-308.
11. Liao JK, Shin WS, Lee WY, Clark SL. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem. 1995;270:319-324.
12. Kume N, Cybulsky MI, Gimbrone MA Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest. 1992;90:1138-1144.
13. Sugiyama S, Kugiyama K, Ohgushi M, Fujimoto K, Yasue H. Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries: role of protein kinase C. Circ Res. 1994;74:565-575.
14. Quinn MT, Parthasarathy S, Steinberg D. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci U S A. 1988;85:2805-2809.
15. Oishi K, Raynor RL, Charp PA, Kuo JF. Regulation of protein kinase C by lysophospholipids: potential role in signal transduction. J Biol Chem. 1988;263:6865-6871.
16. Nishizuka Y. Studies and perspectives of protein kinase C. Science. 1986;233:305-312.
17. Sasaki Y, Asaoka Y, Nishizuka Y. Potentiation of diacylglycerol-induced activation of protein kinase C by lysophospholipids. FEBS Lett. 1993;320:47-51.
18. Kugiyama K, Ohgushi M, Sugiyama S, Murohara T, Fukunaga K, Miyamoto E, Yasue H. Lysophosphatidylcholine inhibits surface receptor-mediated intracellular signals in endothelial cells by a pathway involving protein kinase C activation. Circ Res. 1992;71: 1422-1428.
19. Ohara Y, Peterson TE, Zheng B, Kuo JF, Harnson DO. Lysophosphatidylcholine increases vascular superoxide anion production via protein kinase C activation. Arterioscler Thromb. 1994; 14:1007-1013.
20. Geng JG, Bevilacqua MP, Moore KL, McIntyre TM, Prescott SM, Kirn JM, Bliss GA, Zimmerman GA, McEver RP. Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature. 1990;343:757-760.
21. McEver RP. Properties of GMP-140, an inducible granule membrane protein of platelets and endothelium. J Cell Biochem. 1991;45:156-161.
22. Zimmerman GA, Prescott SM, McIntyre TM. Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol Today. 1992;13:93-99.
23. Sano K, Takai Y, Yamanishi J, Nishizuka Y. A role of calcium-activated phospholipid-dependent protein kinase in human platelet activation. J Biol Chem. 1983;258:2010-2013.
24. Handa K, Igarashi Y, Nisar M, Hakomori S. Downregulation of GMP-140 (CD62 or PADGEM) expression on platelets by N,N-dimethyl and N,N,N-trimethyl derivatives of sphingosine. Biochemistry. 1991;30:11682-11686.
25. Murohara T, Buerke M, Margiotta J, Ruan F, Igarashi Y, Hakomori S, Lefer AM. Myocardial and endothelial protection by TMS in ischemia reperfusion injury. Am J Physiol. 1995;269: H504-H514.
26. Hannun YA, Greenberg CS, Bell RM. Sphingosine inhibition of agonist-dependent secretion and activation of human platelets implies that protein kinase C is a necessary and common event of the signal transduction pathways. J Biol Chem. 1987;262: 13620-13626.
27. Sakai A, Kume N, Ochi H, Nishi E, Moriwaki H, Tanoue K, Kita T. P-Selectin and VCAM-1 are focally expressed in hypercholesterolemic rabbits prior to intimai accumulation of macrophages and T lymphocytes. Circulation. 1995;92(suppl I):I-558-I-559. Abstract.
28. Gauthier TW, Scalia R, Murohara T, Guo JP, Lefer AM. Nitric oxide protects against leukocyte-endothelial interaction of early hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1995;15: 1652-1659.
29. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingbam ME. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 1992;90:1168-1172.
30. DeCaterina R, Libby P, Peng H, Thannickol VJ, Rajavashisth TB, Gimbrone MA Jr, Shin WS, Liao JK. Nitric oxide decreases cytokine-induced endothelial activation: NO selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest. 1995;96:60-68.
31. Murohara T, Parkinson SJ, Waldman SA, Lefer AM. Inhibition of nitric oxide biosynthesis promotes P-selectin expression on platelets: role of protein kinase C. Arterioscler Thromb Vasc Biol. 1995; 15:2068-2075.
32. Akinaga S, Gomi K, Morimoto M, Tamaoki T, Okabe M. Antitumor activity of UCN-01, a selective inhibitor of protein kinase C, in murine and human tumor models. Cancer Res. 1991;51: 4888-4892.
33. Toomik R, Ekman P, Eller M, Jary J, Zaitsev D, Myasoedov N, Ragnarsson U, Engstrom L. Protein kinase assay using tritiated peptide substrates and ferric adsorbent paper for phosphopeptide binding. Anal Biochem. 1993;209:348-353.
34. Gornall AG, Bardowill CT, David MM. Determination ot serum protein by means of the biuret method. J Biol Chem. 1949;177: 751-766.
35. Weyrich AS, Ma X, Buerke M, Murohara T, Armstead VE, Lefer AM, Nicolas JM, Thomas AP, Lefer DJ, Vinten-Johansen J. Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle. Circ Res. 1994;75:692-700.
36. Yuan Y, Fleming BP. A method for isolation and fluorescent labeling of rat neutrophils for intravital microvascular studies. Microvasc Res. 1990;40:218-229.
37. Beckstead JH, Stenberg PE, McEver RP, Shuman MC, Bainton DF. Immunohistochemical localization of membrane and α-granule proteins in human megakaryocytes: application to plastic embedded bone marrow biopsy specimens. Blood. 1986;67:285-293.
38. Weyrich AS, Ma X, Lefer DJ, Albertine KH, Lefer AM. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest. 1993; 91:2620-2629.
39. Murohara T, Buerke M, Lefer AM. Polymorphonuclear leukocyte-induced vasocontraction and endothelial dysfunction: role of selectins. Arterioscler Thromb. 1994;14:1509-1519.
40. Mangin EL Jr, Kugiyama K, Nguy JH, Kerns SA, Henry PD. Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta. Circ Res. 1993; 72:161-166.
41. Portman OW, Soltys P, Alexander M, Osuga T. Metabolism of lysolecithin in vivo: effects of hyperlipemia and atherosclerosis in squirrel monkeys. J Lipid Res. 1970;2:596-604.
42. Vidaver GA, Ting A, Lee JW. Evidence that lysolecithin is an important causal agent of atherosclerosis. J Theor Biol. 1985;115: 27-41.
43. Mohands N, Wyatt J, Mel SF, Rossi ME, Shohet SB. Lipid translocation across the human erythrocyte membrane: regulatory factors. J Biol Chem. 1982;257:6537-6543.
44. Seynaeve CM, Kazanietz MG, Blumberg PM, Sausville EA, Worland PJ. Differential inhibition of protein kinase C isozymes by UCN-01, a staurosporine analogue. Mol Pharmacol. 1994;45: 1207-1214.
45. Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, Bamshad B, Esterson M, Fogelman AM. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest. 1990;85:1260-1266.
46. Vora DK, Fang ZT, Parhad F, Fogelman AM, Territo MC, Berliner JA. P-Selectin induction by MM-LDL and its expression in human atherosclerotic lesions. Circulation. 1994;90(suppl I):I-83. Abstract.
47. Johnson RC, Mayadas TN, Frenette PS, Mebius RE. Subramaniam M, Lacasce A, Hynes RO, Wagner DD. Blood cell dynamics in P-selectin-deficient mice. Blood. 1995;86:1106-1114.
48. Cayatte AJ, Palacino JJ, Horten K, Cohen RA. Chronic inhibition of nitric oxide production accelerates neointimal formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb. 1994;14:753-759.
49. Gopalakrishna R, Chen ZH, Gundimeda U. Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding. J Biol Chem. 1993;268: 27180-27185.
50. Takai Y, Kaibuchi K, Matsubara T, Nishizuka Y. Inhibitory action of guanosine 3′, 5′-monophosphate on thrombin-induced phosphatidylinositol turnover and protein phosphorylation in human platelets. Biochem Biophys Res Commun. 1981;101:61-67.
51. Rubanyi GM, Vanhoutte PM. Oxygen-derived free radicals, endothelium and responsiveness of vascular smooth muscle. Am J Physiol. 1986;250:H815-H821.
52. Patel KD, Zimmerman GA, Prescott SM, McEver RP, McIntyre TM. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J Cell Biol. 1991;112:749-759.
53. Murohara T, Kugiyama K, Ohgushi M, Sugiyama S, Ohta Y, Yasue H. LPC in oxidized LDL elicits vasocontraction and inhibits endothelium-dependent relaxation. Am J Physiol. 1994;267:H2441-H2449.
54. Larsen E, Celi A, Gilbert GE, Furie BC, Erban JK, Bonfanti R, Wagner DD, Furie B. PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell. 1989;59:305-312.